Literature DB >> 29685649

Polygenic link between blood lipids and amyotrophic lateral sclerosis.

Xu Chen1, Solmaz Yazdani2, Fredrik Piehl3, Patrik K E Magnusson2, Fang Fang2.   

Abstract

Dyslipidemia is common among patients with amyotrophic lateral sclerosis (ALS). We aimed to test the association and causality between blood lipids and ALS, using polygenic analyses on the summary results of genome-wide association studies. Polygenic risk scores (PRSs) based on low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) risk alleles were significantly associated with a higher risk of ALS. Using single nucleotide polymorphisms (SNPs) specifically associated with LDL-C and TC as the instrumental variables, statistically significant causal effects of LDL-C and TC on ALS risk were identified in Mendelian randomization analysis. No significant association was noted between PRSs based on triglycerides or high-density lipoprotein cholesterol risk alleles and ALS, and the PRSs based on ALS risk alleles were not associated with any studied lipids. This study supports that high levels of LDL-C and TC are risk factors for ALS, and it also suggests a causal relationship of LDL-C and TC to ALS.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Blood lipids; Genome-wide association studies; Mendelian randomization study; Polygenic risk score

Mesh:

Substances:

Year:  2018        PMID: 29685649     DOI: 10.1016/j.neurobiolaging.2018.03.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

Review 1.  Lipid Metabolic Alterations in the ALS-FTD Spectrum of Disorders.

Authors:  Juan Miguel Godoy-Corchuelo; Luis C Fernández-Beltrán; Zeinab Ali; María J Gil-Moreno; Juan I López-Carbonero; Antonio Guerrero-Sola; Angélica Larrad-Sainz; Jorge Matias-Guiu; Jordi A Matias-Guiu; Thomas J Cunningham; Silvia Corrochano
Journal:  Biomedicines       Date:  2022-05-10

2.  Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis.

Authors:  Jin-Yue Li; Li-Ying Cui; Xiao-Han Sun; Dong-Chao Shen; Xun-Zhe Yang; Qing Liu; Ming-Sheng Liu
Journal:  Ann Clin Transl Neurol       Date:  2022-05-18       Impact factor: 5.430

Review 3.  A review of Mendelian randomization in amyotrophic lateral sclerosis.

Authors:  Thomas H Julian; Sarah Boddy; Mahjabin Islam; Julian Kurz; Katherine J Whittaker; Tobias Moll; Calum Harvey; Sai Zhang; Michael P Snyder; Christopher McDermott; Johnathan Cooper-Knock; Pamela J Shaw
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

4.  Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.

Authors:  James C Dodge; Elizabeth H Jensen; Jinlong Yu; S Pablo Sardi; Allison R Bialas; Tatyana V Taksir; Dinesh S Bangari; Lamya S Shihabuddin
Journal:  J Neurosci       Date:  2020-10-13       Impact factor: 6.167

5.  Statin Medications and Amyotrophic Lateral Sclerosis Incidence and Mortality.

Authors:  Marc G Weisskopf; Joseph Levy; Aisha S Dickerson; Sabrina Paganoni; Maya Leventer-Roberts
Journal:  Am J Epidemiol       Date:  2022-06-27       Impact factor: 5.363

Review 6.  Exploring Sphingolipid Implications in Neurodegeneration.

Authors:  Alice V Alessenko; Elisabetta Albi
Journal:  Front Neurol       Date:  2020-05-21       Impact factor: 4.003

7.  Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis.

Authors:  Sara Bandres-Ciga; Alastair J Noyce; Gibran Hemani; Aude Nicolas; Andrea Calvo; Gabriele Mora; Pentti J Tienari; David J Stone; Mike A Nalls; Andrew B Singleton; Adriano Chiò; Bryan J Traynor
Journal:  Ann Neurol       Date:  2019-03-13       Impact factor: 10.422

8.  Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis.

Authors:  Kjetil Bjornevik; Éilis J O'Reilly; Marianna Cortese; Jeremy D Furtado; Laurence N Kolonel; Loic Le Marchand; Marjorie L Mccullough; Sabrina Paganoni; Michael A Schwarzschild; Aladdin H Shadyab; Joann E Manson; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-09-28       Impact factor: 4.092

9.  Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study.

Authors:  Ping Zeng; Xiang Zhou
Journal:  Hum Mol Genet       Date:  2019-02-15       Impact factor: 6.150

10.  Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis.

Authors:  Caroline Ingre; Lin Chen; Yiqiang Zhan; Jet Termorshuizen; Li Yin; Fang Fang
Journal:  Neurology       Date:  2020-03-27       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.